Search for Clinical Trial Results
Plaque, Atherosclerotic - 25 Studies Found
Status | Study |
Recruiting |
Study Name: Atherosclerotic Plaque Characteristics Associated With a Progression Rate of the Plaque in Carotids and a Risk of Stroke Condition: Carotid Artery Plaque Date: 2015-01-26 |
Active, not recruiting |
Study Name: A Proposed Study of Atherosclerotic Plaques in Leg Arteries Condition:
Date: 2012-09-18 |
Completed |
Study Name: Identification of Genes Expressed in Atherosclerotic Plaque Condition: Atherosclerosis Date: 2006-07-18 |
Withdrawn |
Study Name: Early Therapeutic Effects of Statins and Fibrates on Unstable Atherosclerotic Plaques Condition: Atherosclerosis Date: 2005-10-21 Interventions:
|
Withdrawn |
Study Name: Effects of Intensive Lipid Lowering and Omega-3 Fatty Acid on Composition of Coronary Atherosclerotic Plaque Condition: Acute Coronary Syndrome Date: 2008-09-25 Interventions:
|
Completed |
Study Name: Fractional Flow Reserve (FFR) Versus Instant Wave-Free Ratio (iFR) Condition:
Date: 2012-02-14 |
Completed |
Study Name: Anti-inflammatory Effect of Atorvastatin in Atherosclerotic Plaques Assessed by FDG-PET Imaging Condition:
Date: 2009-06-12 Interventions:
|
Recruiting |
Study Name: The Preventive Implantation of Bioresorbable Vascular Scaffold on Functionally Insignificant Stenosis With Vulnerable Plaque Characteristics Condition:
Date: 2014-12-01 Interventions:
|
Enrolling by invitation |
Study Name: Effect of Subcutaneous ACTEMRA on Inflamed Atherosclerotic Plaques in Patients With Rheumatoid Arthritis Condition: Rheumatoid Arthritis Date: 2015-12-21 Interventions: Drug: tocilizumab subjects will be treated with 162mg of weekly subcutaneous tocilizumab in an open-labe |
Recruiting |
Study Name: Assessment of Atherosclerotic Plaque Characteristics Change by DCE-MRI With Alirocumab Condition:
Date: 2016-11-30 Interventions: Drug: Alirocumab Injectable prescription medicine called a PCSK9 inhibitor. |